Oral Microbiota Perturbations Are Linked to High Risk for Rheumatoid Arthritis/Experiment 1

From BugSigDB


Reviewed Marked as Reviewed by Peace Sandy on 2024-1-21

Curated date: 2021/08/16

Curator: Tislam

Revision editor(s): Tislam, WikiWorks, Peace Sandy

Subjects

Location of subjects
China
Host species Species from which microbiome was sampled. Contact us to have more species added.
Homo sapiens
Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
Saliva Sailva normalis,Saliva atomaris,Saliva molecularis,Salivary gland secretion,Saliva,saliva
Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
Rheumatoid arthritis Arthritis or polyarthritis, rheumatic,arthritis or polyarthritis, rheumatic,Arthritis, Rheumatoid,arthritis, rheumatoid,atrophic Arthritis,atrophic arthritis,autoimmune arthritis,Chronic rheumatic arthritis,Proliferative arthritis,RA,RA - Rheumatoid arthritis,RhA - Rheumatoid arthritis,Rheumatic gout,rheumatoid arthritis,Rheumatoid arthritis (disorder),Rheumatoid arthritis NOS,Rheumatoid arthritis NOS (disorder),rheumatoid arthritis, susceptibility to,Rheumatoid disease,Rheumatoid arthritis
Group 0 name Corresponds to the control (unexposed) group for case-control studies
Healthy controls
Group 1 name Corresponds to the case (exposed) group for case-control studies
Pre - High risk Patients
Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
Pre, “pre-clinical” at risk for RA individuals; RF, rheumatoid factor; ACPA, anti-citrullinated protein antibodies;
Group 0 sample size Number of subjects in the control (unexposed) group
23
Group 1 sample size Number of subjects in the case (exposed) group
29
Antibiotics exclusion Number of days without antibiotics usage (if applicable) and other antibiotics-related criteria used to exclude participants (if any)
Individuals having a history of antibiotics treatment or surgery in the last 3 months were excluded

Lab analysis

Sequencing type
16S
16S variable region One or more hypervariable region(s) of the bacterial 16S gene
V3-V4
Sequencing platform Manufacturer and experimental platform used for quantifying microbial abundance
Illumina

Statistical Analysis

Data transformation Data transformation applied to microbial abundance measurements prior to differential abundance testing (if any).
relative abundances
Statistical test
LEfSe
Significance threshold p-value or FDR threshold used for differential abundance testing (if any)
0.05
MHT correction Have statistical tests be corrected for multiple hypothesis testing (MHT)?
Yes
LDA Score above Threshold for the linear discriminant analysis (LDA) score for studies using the popular LEfSe tool
3
Matched on Factors on which subjects have been matched on in a case-control study
age, ethnic group, sex

Alpha Diversity

Shannon Estimator of species richness and species evenness: more weight on species richness
decreased
Richness Number of species
decreased
Faith Phylogenetic diversity, takes into account phylogenetic distance of all taxa identified in a sample
decreased

Signature 1

Reviewed Marked as Reviewed by Peace Sandy on 2024-1-21

Curated date: 2021/08/16

Curator: Tislam

Revision editor(s): Tislam, Atrayees, Peace Sandy

Source: Figure 3B, text

Description: FIGURE 3 LEfSe analysis revealed the specific taxa changes in high-risk individuals (Pre) and RA patients. LefSe analysis was applied to identify differentially abundant taxa and for which the LDA scores more than 3 are shown (B). LefSe, the LDA effect size. *p < 0.05; **p < 0.01; and ***p < 0.001.

Abundance in Group 1: increased abundance in Pre - High risk Patients

NCBI Quality ControlLinks
Bacillales
Gemella

Revision editor(s): Tislam, Atrayees, Peace Sandy

Signature 2

Reviewed Marked as Reviewed by Peace Sandy on 2024-1-21

Curated date: 2021/08/17

Curator: Tislam

Revision editor(s): Tislam, Peace Sandy

Source: Figure 3, text

Description: FIGURE 3 LEfSe analysis revealed the specific taxa changes in high-risk individuals (Pre) and RA patients. LefSe analysis was applied to identify differentially abundant taxa and for which the LDA scores more than 3 are shown (B). LefSe, the LDA effect size. *p < 0.05; **p < 0.01; and ***p < 0.001.

Abundance in Group 1: decreased abundance in Pre - High risk Patients

NCBI Quality ControlLinks
Filifactor
Gammaproteobacteria
Haemophilus
Neisseria
Neisseriaceae
Pasteurellaceae
Pasteurellales
Porphyromonadaceae
Porphyromonas
Pseudomonadales
Pseudomonadota
Spirochaeta
Spirochaetaceae
Spirochaetales
Spirochaetia

Revision editor(s): Tislam, Peace Sandy